Thousands of people living with obesity in England are set to be offered Wegovy, also known as semaglutide, on prescription after health officials approved its use for weight loss.
But the “pivotal moment” for weight loss has already been hit by supply chain issues and it is currently unclear whether the company that makes the jab, Novo Nordisk, will be able to adequately supply the NHS.
The NHS will only be able to roll out the drug within 90 days of it being made commercially available to the health service by the manufacturer – something that has not yet happened.
Read more at: https://news.sky.com/story/wegovy-nhs-weight-loss-jab-already-having-supply-issues-as-private-clinics-stockpile-12828754
